NCT05386459View on ClinicalTrials.gov

Study of the Use of the Drug Ingaron in Patients With COVID-19

CompletedOBSERVATIONAL
Enrollment

36

Participants

Timeline

Start Date

April 21, 2020

Primary Completion Date

June 17, 2020

Study Completion Date

October 1, 2020

Conditions
COVID-19 Respiratory InfectionViral Pneumonia
Interventions
DRUG

Interferon Gamma

injection form

Trial Locations (1)

121374

City Clinical Hospital named after M.E. Zhadkevich Moscow City Health Department, Moscow

All Listed Sponsors
lead

SPP Pharmaclon Ltd.

INDUSTRY

NCT05386459 - Study of the Use of the Drug Ingaron in Patients With COVID-19 | Biotech Hunter | Biotech Hunter